Biotech Updates

Solae Discusses Omega-3 from GM Soybean at IFT

July 23, 2010

For the past years, researchers have been working on sourcing omega-3 fatty acids from plants for human use. Thus, Solae and Monsanto collaborated in 2007 to commercialize steariodonic acid omega-3 from genetically modified soybeans. Last year, it already attained GRAS (generally recognized as safe) status and Solae is now sending out samples to possible customers for trial and also discussed it for the first time at the Institute of Food Technologists (IFT) tradeshow in Chicago last week.

Solae marketing and sales director Al Gallegos said that "the new ingredient, called Soymega, has been successfully tested for use in soups, sauces, yoghurts, dressings, snack bars, industrial margarines and shortenings." They are expecting to complete the process of regulatory approval in the US by 2012.

Visit http://www.nutraingredients-usa.com/Industry/Solae-discussing-omega-3-form-soy-at-IFT to read the complete article.